Guardant Health Inc. (GH)
NASDAQ: GH
· Real-Time Price · USD
60.70
-1.95 (-3.11%)
At close: Oct 02, 2025, 1:04 PM
-3.11% (1D)
| Bid | 60.68 |
| Market Cap | 7.57B |
| Revenue (ttm) | 828.85M |
| Net Income (ttm) | -413.82M |
| EPS (ttm) | -3.49 |
| PE Ratio (ttm) | -17.39 |
| Forward PE | -22.8 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 60.71 |
| Volume | 1,247,962 |
| Avg. Volume (20D) | 2,708,769.1 |
| Open | 62.60 |
| Previous Close | 62.65 |
| Day's Range | 60.45 - 63.00 |
| 52-Week Range | 20.14 - 68.00 |
| Beta | 1.46 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for GH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGuardant Health Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+4.35%
Guardant Health shares are trading higher after mu...
Unlock content with
Pro Subscription
4 weeks ago
-5.69%
Guardant Health shares are trading lower. The company announced clinical readout update assessing the performance of the latest colorectal cancer screening algorithm for its Shield blood test.
